StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.87−0.54 (-7.29%)

Close on Nov 18, 2026Market cap $622.17MP/E –Yield –

Verastem net income

Net income is the profit left for shareholders after every expense, interest and tax.

Verastem's net income for the twelve months ending Jun 30, 2026 was -$202.70M. For fiscal 2025 it was -$209.47M. The highest annual figure on record is -$13.68M in fiscal 2011.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$209.47M–
FY2024Dec 31, 2024-$130.64M–
FY2023Dec 31, 2023-$87.37M–
FY2022Dec 31, 2022-$73.81M–
FY2021Dec 31, 2021-$71.20M–
FY2020Dec 31, 2020-$67.73M–
FY2019Dec 31, 2019-$149.21M–
FY2018Dec 31, 2018-$72.43M–
FY2017Dec 31, 2017-$67.80M–
FY2016Dec 31, 2016-$36.44M–
FY2015Dec 31, 2015-$57.87M–
FY2014Dec 31, 2014-$53.37M–
FY2013Dec 31, 2013-$41.20M–
FY2012Dec 31, 2012-$31.98M–
FY2011Dec 31, 2011-$13.68M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$34.67M–
Q1 FY2026Mar 31, 2026-$36.59M–
Q4 FY2025Dec 31, 2025-$32.92M–
Q3 FY2025Sep 30, 2025-$98.52M–
Q2 FY2025Jun 30, 2025-$25.93M–
Q1 FY2025Mar 31, 2025-$52.10M–
Q4 FY2024Dec 31, 2024-$64.55M–
Q1 FY2024Jun 30, 2024-$42.12M–
Q4 FY2023Dec 31, 2023-$27.37M–
Q3 FY2023Sep 30, 2023-$20.00M–
Q2 FY2023Jun 30, 2023-$24.28M–
Q1 FY2023Mar 31, 2023-$15.71M–
Q4 FY2022Dec 31, 2022-$16.81M–
Q3 FY2022Sep 30, 2022-$18.09M–
Q2 FY2022Jun 30, 2022-$21.95M–
Q1 FY2022Mar 31, 2022-$16.96M–
Q4 FY2021Dec 31, 2021-$16.48M–
Q3 FY2021Sep 30, 2021-$22.79M-273.4%
Q2 FY2021Jun 30, 2021-$16.90M–
Q1 FY2021Mar 31, 2021-$15.03M–
Q4 FY2020Dec 31, 2020-$19.86M–
Q3 FY2020Sep 30, 2020$13.14M–
Q2 FY2020Jun 30, 2020-$23.01M–
Q1 FY2020Mar 31, 2020-$37.99M–
Q4 FY2019Dec 31, 2019-$38.77M–
Q3 FY2019Sep 30, 2019-$30.14M–
Q2 FY2019Jun 30, 2019-$42.19M–
Q1 FY2019Mar 31, 2019-$38.10M–
Q4 FY2018Dec 31, 2018-$11.35M–
Q3 FY2018Sep 30, 2018-$21.67M–
Q2 FY2018Jun 30, 2018-$18.37M–
Q1 FY2018Mar 31, 2018-$21.05M–
Q4 FY2017Dec 31, 2017-$18.24M–
Q3 FY2017Sep 30, 2017-$23.13M–
Q2 FY2017Jun 30, 2017-$13.44M–
Q1 FY2017Mar 31, 2017-$13.01M–
Q4 FY2016Dec 31, 2016-$11.66M–
Q3 FY2016Sep 30, 2016-$7.92M–
Q2 FY2016Jun 30, 2016-$8.57M–

More Verastem figures

See a number that looks wrong?